Signaling networks in RUNX2-dependent bone development

Journal of Cellular Biochemistry

Volumn 112, Issue 3, 2011, Pages 750-755

  Komori, Toshihisa ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Chondrocyte; FGF; IHH; Osteoblast; RUNX2; SP7; WNT

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; PROTEIN SP7; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; WNT PROTEIN; ZINC FINGER PROTEIN;

BONE DEVELOPMENT; BONE MATURATION; CARTILAGE CELL; CELL DIFFERENTIATION; CRANIOFACIAL SYNOSTOSIS; HUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; UPREGULATION;

ANIMALS; BONE DEVELOPMENT; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; HEDGEHOG PROTEINS; HUMANS; OSTEOBLASTS; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 79951792447     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22994     Document Type: Review

References (92)

1. Baek WY, Lee MA, Jung JW, Kim SY, Akiyama H, de Crombrugghe B, Kim JE. 2009. Positive regulation of adult bone formation by osteoblast-specific transcription factor osterix. J Bone Miner Res 24:1055-1065.
2. Beenken A, Mohammadi M. 2009. The FGF family: Biology, pathophysiology and therapy. Nat Rev Drug Discov 8:235-253.
3. Celil AB, Campbell PG. 2005. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 280:31353-31359. (Pubitemid 41291875)
4. Chen L, Adar R, Yang X, Monsonego EO, Li C, Hauschka PV, Yayon A, Deng CX. 1999. Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest 104:1517-1525. (Pubitemid 30002363)
5. Cohen MM. 2004. FGFs/FGFRs and associated disorders. In: Epstein CJ, Erickson RP, Wynshaw-Boris A, editors. Inborn errors of development. New York: Oxford University Press. pp 380-400.
6. Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM. 1996. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 12:390-397. (Pubitemid 26105928)
7. Conen KL, Nishimori S, Provot S, Kronenberg HM. 2009. The transcriptional cofactor Lbh regulates angiogenesis and endochondral bone formation during fetal bone development. Dev Biol 333:348-358.
8. Dai P, Akimaru H, Tanaka Y, Maekawa T, Nakafuku M, Ishii S. 1999. Sonic hedgehog-induced activation of the Gli1 promoter is mediated by GLI3. J Biol Chem 274:8143-8152.
9. Day TF, Guo X, Garrett-Beal L, Yang Y. 2005. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8:739-750. (Pubitemid 40585296)
10. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911-921. (Pubitemid 26106860)
11. Dong YF, Soung do Y, Schwarz EM, O'Keefe RJ, Drissi H. 2006. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J Cell Physiol 208:77-86.
12. Enomoto H, Enomoto-Iwamoto M, Iwamoto M, Nomura S, Himeno M, Kitamura Y, Kishimoto T, Komori T. 2000. Cbfa1 is a positive regulatory factor in chondrocyte maturation. J Biol Chem 275:8695-8702. (Pubitemid 30180221)
13. Eswarakumar VP, Monsonego-Ornan E, Pines M, Antonopoulou I, Morriss-Kay GM, Lonai P. 2002. The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129:3783-3793. (Pubitemid 34994009)
14. Eswarakumar VP, Horowitz MC, Locklin R, Morriss-Kay GM, Lonai P. 2004. A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc Natl Acad Sci USA 101:12555-12560. (Pubitemid 39122062)
15. Fu H, Doll B, McNelis T, Hollinger JO. 2007. Osteoblast differentiation in vitro and in vivo promoted by Osterix. J Biomed Mater Res A 83:770-778. (Pubitemid 350086303)
16. Fujita T, Azuma Y, Fukuyama R, Hattori Y, Yoshida CA, Koida M, Ogita K, Komori T. 2004. Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J Cell Biol 166:85-95. (Pubitemid 38931919)
17. Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB. 2005. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280:33132-33140. (Pubitemid 41397109)
18. Ge C, Xiao G, Jiang D, Yang Q, Hatch NE, Roca H, Franceschi RT. 2009. Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor. J Biol Chem 284:32533-32543.
19. Glass DA II, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G. 2005. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8:751-764. (Pubitemid 40585297)
20. Hamidouche Z, Haÿ E, Vaudin P, Charbord P, Schüle R, Marie PJ, Fromigué O. 2008. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression. FASEB J 22:3813-3822.
21. Hartmann C. 2006. A Wnt canon orchestrating osteoblastogenesis. Trends Cell Biol 16:151-158. (Pubitemid 43358003)
22. Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C. 2005. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8:727-738. (Pubitemid 40585295)
23. Hilton MJ, Tu X, Cook J, Hu H, Long F. 2005. Ihh controls cartilage development by antagonizing Gli3, but requires additional effectors to regulate osteoblast and vascular development. Development 132:4339-4351. (Pubitemid 41576695)
24. Himeno M, Enomoto H, Liu W, Ishizeki K, Nomura S, Kitamura Y, Komori T. 2002. Impaired vascular invasion of Cbfa1-deficient cartilage engrafted in the spleen. J Bone Miner Res 17:1297-1305. (Pubitemid 34680507)
25. Hoeppner LH, Secreto F, Jensen ED, Li X, Kahler RA, Westendorf JJ. 2009. Runx2 and bone morphogenic protein 2 regulate the expression of an alternative Lef1 transcript during osteoblast maturation. J Cell Physiol 221:480-489.
26. Hu H, Hilton MJ, Tu X, Yu K, Ornitz DM, Long F. 2005. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132:49-60. (Pubitemid 40207966)
27. Inada M, Yasui T, Nomura S, Miyake S, Deguchi K, Himeno M, Sato M, Yamagiwa H, Kimura T, Yasui N, Ochi T, Endo N, Kitamura Y, Kishimoto T, Komori T. 1999. Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 214:279-290. (Pubitemid 29160205)
28. Ingham PW, McMahon AP. 2001. Hedgehog signaling in animal development: Paradigms and principles. Genes Dev 15:3059-3087. (Pubitemid 33115673)
29. Iseki S, Wilkie AO, Morriss-Kay GM. 1999. Fgfr1 and Fgfr2 have distinct differentiation-and proliferation-related roles in the developing mouse skull vault. Development 126:5611-5620. (Pubitemid 30035010)
30. Itoh N, Ornitz DM. 2004. Evolution of the Fgf and Fgfr gene families. Trends Genet 20:563-569. (Pubitemid 39314564)
31. Iwamoto M, Kitagaki J, Tamamura Y, Gentili C, Koyama E, Enomoto H, Komori T, Pacifici M, Enomoto-Iwamoto M. 2003. Runx2 expression and action in chondrocytes are regulated by retinoid signaling and parathyroid hormone-related peptide (PTHrP). Osteoarthritis Cartilage 11:6-15. (Pubitemid 36157568)
32. Jacob AL, Smith C, Partanen J, Ornitz DM. 2006. Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev Biol 296:315-328. (Pubitemid 44189342)
33. Javed A, Barnes GL, Pratap J, Antkowiak T, Gerstenfeld LC, van Wijnen AJ, Stein JL, Lian JB, Stein GS. 2005. Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc Natl Acad Sci USA 102:1454-1459. (Pubitemid 40209191)
34. Johnson D, Iseki S, Wilkie AO, Morriss-Kay GM. 2000. Expression patterns of Twist and Fgfr1, -2 and -3 in the developing mouse coronal suture suggest a key role for twist in suture initiation and biogenesis. Mech Dev 91:341-345. (Pubitemid 30125935)
35. Kaback LA, Soung do Y, Naik A, Smith N, Schwarz EM, O'Keefe RJ, Drissi H. 2008. Osterix/Sp7 regulates mesenchymal stem cell mediated endochondral ossification. J Cell Physiol 214:173-182.
36. Kahler RA, Westendorf JJ. 2003. Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. J Biol Chem 278:11937-11944. (Pubitemid 36800167)
37. Kärner E, Unger C, Cerny R, Ahrlund-Richter L, Ganss B, Dilber MS, Wendel M. 2009. Differentiation of human embryonic stem cells into osteogenic or hematopoietic lineages: A dose-dependent effect of osterix over-expression. J Cell Physiol 218:323-333.
38. Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ, Ryoo HM. 2003. The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem 278:319-326.
39. Kim YJ, Kim HN, Park EK, Lee BH, Ryoo HM, Kim SY, Kim IS, Stein JL, Lian JB, Stein GS, van Wijnen AJ, Choi JY. 2006. The bone-related Zn finger transcription factor Osterix promotes proliferation of mesenchymal cells. Gene 366:145-151. (Pubitemid 43199603)
40. Komori T. 2005. Regulation of skeletal development by the Runx family of transcription factors. J Cell Biochem 95:445-453. (Pubitemid 41420175)
41. Kurata H, Guillot PV, Chan J, Fisk NM. 2007. Osterix induces osteogenic gene expression but not differentiation in primary human fetal mesenchymal stem cells. Tissue Eng 13:1513-1523. (Pubitemid 47105759)
42. Li TF, Dong Y, Ionescu AM, Rosier RN, Zuscik MJ, Schwarz EM, O'Keefe RJ, Drissi H. 2004. Parathyroid hormone-related peptide (PTHrP) inhibits Runx2 expression through the PKA signaling pathway. Exp Cell Res 299:128-136. (Pubitemid 39078388)
43. Li C, Xu X, Nelson DK, Williams T, Kuehn MR, Deng CX. 2005. FGFR1 function at the earliest stages of mouse limb development plays an indispensable role in subsequent autopod morphogenesis. Development 132:4755-4764. (Pubitemid 41685285)
44. Li Y, Ge C, Franceschi RT. 2010. Differentiation-dependent association of phosphorylated extracellular signal-regulated kinase with the chromatin of osteoblast-related genes. J Bone Miner Res 25:154-163.
45. Ling L, Dombrowski C, Foong KM, Haupt LM, Stein GS, Nurcombe V, van Wijnen AJ, Cool SM. 2010. Synergism between Wnt3a and heparin enhances osteogenesis via a phosphoinositide 3-kinase/Akt/RUNX2 pathway. J Biol Chem 285:26233-26244.
46. Liu Z, Xu J, Colvin JS, Ornitz DM. 2002. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 16:859-869. (Pubitemid 34280109)
47. Long F, Chung UI, Ohba S, McMahon J, Kronenberg HM, McMahon AP. 2004. Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 131:1309-1318. (Pubitemid 38443885)
48. Maehata Y, Takamizawa S, Ozawa S, Kato Y, Sato S, Kubota E, Hata R. 2006. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: Roles of osterix, an osteoblast-related transcription factor. Matrix Biol 25:47-58. (Pubitemid 43145811)
49. Maes C, Goossens S, Bartunkova S, Drogat B, Coenegrachts L, Stockmans I, Moermans K, Nyabi O, Haigh K, Naessens M, Haenebalcke L, Tuckermann JP, Tjwa M, Carmeliet P, Mandic V, David JP, Behrens A, Nagy A, Carmeliet G, Haigh JJ. 2010. Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bones. EMBO J 20:424-441.
50. Mansukhani A, Ambrosetti D, Holmes G, Cornivelli L, Basilico C. 2005. Sox2 induction by FGF and FGFR2 activating mutations inhibit Wnt signaling and osteoblast differentiation. J Cell Biol 168:1065-1076.
51. Marigo V, Johnson RL, Vortkamp A, Tabin CJ. 1996. Sonic hedgehog differentially regulates expression of GLI and GLI3 during limb development. Dev Biol 180:273-283. (Pubitemid 26426174)
52. Maruyama Z, Yoshida CA, Furuichi T, Amizuka N, Ito M, Fukuyama R, Miyazaki T, Kitaura H, Nakamura K, Fujita T, Kanatani N, Moriishi T, Yamana K, Liu W, Kawaguchi H, Nakamura K, Komori T. 2007. Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. Dev Dyn 236:1876-1890. (Pubitemid 47076017)
53. Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, Aburatani H, Nishimura R, Yoneda T. 2008. BMP2 regulates osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 283:29119-29125.
54. Mbalaviele G, Sheikh S, Stains JP, Salazar VS, Cheng SL, Chen D, Civitelli R. 2005. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J Cell Biochem 94:403-418. (Pubitemid 41420317)
55. Mikasa M, Rokutanda S, Komori H, Ito K, Tsang Y, Date Y, Yoshida CA, Komori T. 2010. Regulation of Tcf7 by Runx2 in chondrocyte maturation and proliferation. J Bone Miner Metab (in press). DOI:10.1007/s00774-010-0222-z
56. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, Doetschman T, Coffin JD, Hurley MM. 2000. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 105:1085-1093. (Pubitemid 30217693)
57. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29. (Pubitemid 34137009)
58. Naski MC, Colvin JS, Coffin JD, Ornitz DM. 1998. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 125:4977-4988. (Pubitemid 29026779)
59. Ohba S, Kawaguchi H, Kugimiya F, Ogasawara T, Kawamura N, Saito T, Ikeda T, Fujii K, Miyajima T, Kuramochi A, Miyashita T, Oda H, Nakamura K, Takato T, Chung UI. 2008. Patched1 haploinsufficiency increases adult bone mass and modulates Gli3 repressor activity. Dev Cell 14:689-699. (Pubitemid 351622616)
60. Ohbayashi N, Shibayama M, Kurotaki Y, Imanishi M, Fujimori T, Itoh N, Takada S. 2002. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 16:870-879. (Pubitemid 34280110)
61. Park OJ, Kim HJ, Woo KM, Baek JH, Ryoo HM. 2010. FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization. J Biol Chem 285:3568-3574.
62. Partanen J, Schwartz L, Rossant J. 1998. Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos. Genes Dev 12:2332-2344. (Pubitemid 28371353)
63. Reinhold MI, Naski MC. 2007. Direct interactions of Runx2 and canonical Wnt signaling induce FGF18. J Biol Chem 282:3653-3663. (Pubitemid 47084474)
64. Rice DP, Aberg T, Chan Y, Tang Z, Kettunen PJ, Pakarinen L, Maxson RE, Thesleff I. 2000. Integration of FGF and TWIST in calvarial bone and suture development. Development 127:1845-1855. (Pubitemid 30311788)
65. Rodda SJ, McMahon AP. 2006. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133:3231-3244. (Pubitemid 44404346)
66. Rodríguez-Carballo E, Ulsamer A, Susperregui AR, Manzanares-Céspedes C, Sánchez-García E, Bartrons R, Rosa JL, Ventura F. 2010. Conserved regulatory motifs in osteogenic gene promoters integrate cooperative effects of canonical Wnt and BMP pathways. J Bone Miner Res 27 [Epub ahead of print]. DOI:10.1002/jbmr.260
67. Ruiz I, Altaba A. 1999. Gli proteins encode context-dependent positive and negative functions: Implications for development and disease. Development 126:3205-3216. (Pubitemid 29378183)
68. Sasaki H, Nishizaki Y, Hui C, Nakafuku M, Kondoh H. 1999. Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: Implication of Gli2 and Gli3 as primary mediators of Shh signaling. Development 126:3915-3924. (Pubitemid 29440488)
69. Sharpe C, Lawrence N, Martinez Arias A. 2001. Wnt signalling: A theme with nuclear variations. BioEssays 23:311-318. (Pubitemid 32285755)
70. Shimoyama A, Wada M, Ikeda F, Hata K, Matsubara T, Nifuji A, Noda M, Amano K, Yamaguchi A, Nishimura R, Yoneda T. 2007. Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol Biol Cell 18:2411-2418. (Pubitemid 47025707)
71. Shukla V, Coumoul X, Wang RH, Kim HS, Deng CX. 2007. RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. Nat Genet 39:1145-1150. (Pubitemid 47340648)
72. St-Jacques B, Hammerschmidt M, McMahon AP. 1999. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 13:2072-2086. (Pubitemid 29407348)
73. Sun L, Vitolo M, Passaniti A. 2001. Runt-related gene 2 in endothelial cells: Inducible expression and specific regulation of cell migration and invasion. Cancer Res 61:4994-5001. (Pubitemid 32681526)
74. Sun X, Wei L, Chen Q, Terek RM. 2009. HDAC4 represses vascular endothelial growth factor expression in chondrosarcoma by modulating RUNX2 activity. J Biol Chem 284:21881-21890.
75. Takeda S, Bonnamy JP, Owen MJ, Ducy P, Karsenty G. 2001. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genws-Genes Dev 15:467-481. (Pubitemid 32187007)
76. Tanimoto Y, Yokozeki M, Hiura K, Matsumoto K, Nakanishi H, Matsumoto T, Marie PJ, Moriyama K. 2004. A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome. J Biol Chem 279:45926-45934. (Pubitemid 39491585)
77. Tominaga H, Maeda S, Miyoshi H, Miyazono K, Komiya S, Imamura T. 2009. Expression of osterix inhibits bone morphogenetic protein-induced chondrogenic differentiation of mesenchymal progenitor cells. J Bone Miner Metab 27:36-45.
78. Tu Q, Valverde P, Chen J. 2006. Osterix enhances proliferation and osteogenic potential of bone marrowstromal cells. Biochem Biophys Res Commun 341:1257-1265. (Pubitemid 43221800)
79. Turner N, Grose R. 2010. Fibroblast growth factor signalling: From development to cancer. Nat Rev Cancer 10:116-129.
80. Ueta C, Iwamoto M, Kanatani N, Yoshida C, Liu Y, Enomoto-Iwamoto M, Ohmori T, Enomoto H, Nakata K, Takada K, Kurisu K, Komori T. 2001. Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J Cell Biol 153:87-100.
81. -/- mice. Hum Mol Genet 13:271-284.
82. Verheyden JM, Lewandoski M, Deng C, Harfe BD, Sun X. 2005. Conditional inactivation of Fgfr1 in mouse defines its role in limb bud establishment, outgrowth and digit patterning. Development 132:4235-4245. (Pubitemid 41576686)
83. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ. 1996. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273:613-622. (Pubitemid 26262108)
84. Wang B, Fallon JF, Beachy PA. 2000. Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell 100:423-434.
85. Wilkie AO, Patey SJ, Kan SH, van den Ouweland AM, Hamel BC. 2002. FGFs, their receptors, and human limb malformations: Clinical and molecular correlations. Am J Med Genet 112:266-278.
86. Xiao G, Jiang D, Gopalakrishnan R, Franceschi RT. 2002. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem 277:36181-36187.
87. Xu W, Kimelman D. 2007. Mechanistic insights from structural studies of β-catenin and its binding partners. J Cell Sci 120:3337-3344. (Pubitemid 350028341)
88. Yoshida CA, Yamamoto H, Fujita T, Furuichi T, Ito K, Inoue K, Yamana K, Zanma A, Takada K, Ito Y, Komori T. 2004. Runx2 and Runx3 are essential for chondrocyte maturation and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev 18:952-963. (Pubitemid 38529663)
89. Yu K, Xu J, Liu Z, Sosic D, Shao J, Olson EN, Towler DA, Ornitz DM. 2003. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130:3063-3074. (Pubitemid 36857252)
90. Zelzer E, Glotzer DJ, Hartmann C, Thomas D, Fukai N, Soker S, Olsen BR. 2001. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 106:97-106. (Pubitemid 32701077)
91. Zhou YX, Xu X, Chen L, Li C, Brodie SG, Deng CX. 2000. A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum Mol Genet 9:2001-2008.
92. J Cell Physiol 2009. 221:480-489.